Literature DB >> 3654696

Dislocation of the acromioclavicular joint. An end-result study.

T N Taft1, F C Wilson, J W Oglesby.   

Abstract

The cases of 127 patients who had an acute dislocation of the acromioclavicular joint were studied. Fifty-two patients, with an average follow-up of 10.8 years, were managed operatively, and seventy-five patients, with an average follow-up of 9.5 years, were managed non-operatively. Using a rating system that included subjective, objective, and roentgenographic criteria, it did not appear that reduction of the acromioclavicular joint was necessary to obtain consistently good results. Operative management, using either coracoclavicular or acromioclavicular fixation, was associated with a higher rate of complications than non-operative treatment. The use of a sling for four weeks without reduction of the joint, followed by a graduated exercise program, led to acceptable clinical results. In patients who had persistent pain and stiffness of the acromioclavicular joint, or in whom symptomatic post-traumatic arthritis developed, resection of the distal part of the clavicle reliably produced significant improvement.

Entities:  

Mesh:

Year:  1987        PMID: 3654696

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  72 in total

1.  Inter- and intraobserver reliability of the Rockwood classification in acute acromioclavicular joint dislocations.

Authors:  M M Schneider; M Balke; P Koenen; M Fröhlich; A Wafaisade; B Bouillon; M Banerjee
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2014-11-16       Impact factor: 4.342

2.  [The surgical treatment of acromioclavicular joint separation with a resorbable PDS cord].

Authors:  M Rustemeier; H A Kulenkampff
Journal:  Unfallchirurgie       Date:  1990-04

3.  Comment by the author.

Authors:  Tim T Lögters
Journal:  Eur J Trauma Emerg Surg       Date:  2009-08       Impact factor: 3.693

Review 4.  [Current procedures for clinical evaluation of the shoulder].

Authors:  M Scheibel; P Habermeyer
Journal:  Orthopade       Date:  2005-03       Impact factor: 1.087

5.  [The use of Debrecen plates in the management of acromioclavicular dislocation].

Authors:  S Sánta; Z Zaborsky; Z Varga
Journal:  Unfallchirurgie       Date:  1991-12

6.  Current state of treatment of acute acromioclavicular joint injuries in Germany: is there a difference between specialists and non-specialists? A survey of German trauma and orthopaedic departments.

Authors:  Maurice Balke; Marco M Schneider; Sven Shafizadeh; Holger Bäthis; Bertil Bouillon; Marc Banerjee
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2013-12-04       Impact factor: 4.342

7.  Acromioclavicular motion after surgical reconstruction.

Authors:  Pierorazio Motta; Laura Bruno; Alberto Maderni; Piermario Tosco; Umberto Mariotti
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2011-08-03       Impact factor: 4.342

Review 8.  Operative or conservative treatment in patients with Rockwood type III acromioclavicular dislocation: a systematic review and update of current literature.

Authors:  Koos Korsten; Amy C Gunning; Luke P H Leenen
Journal:  Int Orthop       Date:  2013-10-31       Impact factor: 3.075

9.  Why does minimally invasive coracoclavicular ligament reconstruction using a flip button repair technique fail? An analysis of risk factors and complications.

Authors:  Benedikt Schliemann; Steffen B Roßlenbroich; Kristian N Schneider; Christina Theisen; Wolf Petersen; Michael J Raschke; André Weimann
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2013-10-30       Impact factor: 4.342

10.  Open capsular and ligament reconstruction with semitendinosus hamstring autograft successfully controls superior and posterior translation for type V acromioclavicular joint dislocation.

Authors:  Raffaele Garofalo; Enrico Ceccarelli; Alessandro Castagna; Vittorio Calvisi; Brody Flanagin; Marco Conti; Sumant G Krishnan
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2017-04-22       Impact factor: 4.342

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.